Prefer a chat interface with context about you and your work?
Bayesian Meta‐Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Summary Recent guidance from the Food and Drug Administration for the evaluation of new therapies in the treatment of type 2 diabetes (T2DM) calls for a program‐wide meta‐analysis of cardiovascular (CV) outcomes. In this context, we develop a new Bayesian meta‐analysis approach using survival regression models to assess whether the …